First Bancorp’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,200
Closed -$217K 134
2025
Q3
$217K Hold
2,200
0.12% 123
2025
Q2
$201K Sell
2,200
-75
-3% -$7.25K 0.12% 127
2025
Q1
$257K Sell
2,275
-1,870
-45% -$200K 0.17% 109
2024
Q4
$442K Buy
4,145
+2,175
+110% +$233K 0.3% 76
2024
Q3
$213K Hold
1,970
0.15% 119
2024
Q2
$214K Hold
1,970
0.16% 113
2024
Q1
$260K Buy
1,970
+100
+5% +$12.5K 0.2% 99
2023
Q4
$228K Sell
1,870
-75
-4% -$8.37K 0.18% 103
2023
Q3
$218K Hold
1,945
0.19% 103
2023
Q2
$283K Sell
1,945
-175
-8% -$23.8K 0.23% 85
2023
Q1
$274K Buy
2,120
+100
+5% +$12.6K 0.23% 88
2022
Q4
$258K Hold
2,020
0.22% 90
2022
Q3
$211K Buy
+2,020
New +$222K 0.19% 100

Other funds holding ZBH

First Bancorp's ZBH Position: Q4 2025 in Review

First Bancorp sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 2,200 shares — an estimated $217K sold.

First Bancorp first reported a position in ZBH in Q3 2022 and held it in 13 quarters. The position peaked at $442K in Q4 2024. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • First Bancorp reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • First Bancorp sold 2,200 Zimmer Biomet shares in Q4 2025, an estimated $217K.
  • First Bancorp first reported a position in Zimmer Biomet in Q3 2022 and held it in 13 quarters.
  • First Bancorp's Zimmer Biomet position peaked at $442K in Q4 2024.
  • 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on First Bancorp's 13F filing for Q4 2025, filed 26 Jan 2026.